Jong‐Mu Sun

12.3k citations
237 papers · 7.3k · 3 hit papers · h-index 45

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment

Papers in

    • Lung Cancer Treatments and Mutations 100
    • Lung Cancer Diagnosis and Treatment 22
    • Gastric Cancer Management and Outcomes 18
    • Cancer Immunotherapy and Biomarkers 37
    • Lung Cancer Research Studies 25
    • Colorectal Cancer Treatments and Studies 21

Jong‐Mu Sun

232 papers receiving 7.2k citations

Jong‐Mu Sun's Hit Papers

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) 2019 · 242 citations
2420+5+10Years since publication100200300

Peers

Jong‐Mu Sun
Comparison fields: 5 of 114
  • Oncology 3.5k
  • Pulmonary and Respiratory Medicine 3.7k
  • Cancer Research 751
  • Otorhinolaryngology 157
  • Immunology 551
Replace Rafael Rosell with:
Rafael Rosell Spain
Howard Safran United States
Daniel Castellano Spain
Sakae Okumura Japan
Baek‐Yeol Ryoo South Korea
Kari Chansky United States
Wilfried Eberhardt Germany
Caroline Caramella France
Wallace Akerley United States
Tibor Csőszi United States
Jong‐Mu Sun relative to Rafael Rosell Spain Rafael Rosell's profile →
Citations per field
00.5×7.5×
Rafael Rosell · 1×
Citations per year

Countries citing papers authored by Jong‐Mu Sun

Since Specialization
Citations

This map shows the geographic impact of Jong‐Mu Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong‐Mu Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong‐Mu Sun more than expected).

Fields of papers citing papers by Jong‐Mu Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong‐Mu Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong‐Mu Sun. The network helps show where Jong‐Mu Sun may publish in the future.

Co-authors

The 25 scholars most cited alongside Jong‐Mu Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jong‐Mu Sun Line = papers co-authored together Jong‐Mu Sun links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 237 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study
Hit paper breakdown →
2011351
2
Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)
Hit paper breakdown →
2019242
3
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Hit paper breakdown →
2018237
4 2017177
5 2016168
6 2017143
7 2013140
8 2019137
9 2019135
10 2020127
11 2019127
12 2012126
13 2015116
14 2018116
15 2015109
16 2020108
17 2011101
18 2019101
19 202097
20 201395

About Jong‐Mu Sun

Jong‐Mu Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology and Cancer Research, having authored 237 papers that have together received 7.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (100 papers), Cancer Immunotherapy and Biomarkers (37 papers), Lung Cancer Research Studies (25 papers), Lung Cancer Diagnosis and Treatment (22 papers), Colorectal Cancer Treatments and Studies (21 papers), Esophageal Cancer Research and Treatment (19 papers), Gastric Cancer Management and Outcomes (18 papers) and Cancer Genomics and Diagnostics (12 papers). The work is most often cited by research in Oncology (3.5k citations), Pulmonary and Respiratory Medicine (3.7k citations), Cancer Research (751 citations), Otorhinolaryngology (157 citations) and Immunology (551 citations). Jong‐Mu Sun has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Myung‐Ju Ahn, Keunchil Park, Jin Seok Ahn, Se‐Hoon Lee, Yoon‐La Choi, Bo Mi Ku, Hyun Ae Jung, Joungho Han, Sung Hee Lim and Myung‐Ju Ahn. Their work appears in journals such as Journal of Thoracic Oncology, Journal of Clinical Oncology, Lung Cancer, Cancer Research and Treatment and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact